Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-lnducing ligand by elimination of Mcl-1

Saved in:
Bibliographic Details
Published inCancer research (Chicago, Ill.) Vol. 65; no. 16; pp. 7393 - 7402
Main Authors WIRTH, Thomas, KÜHNEL, Florian, FLEISCHMANN-MUNDT, Bettina, WOLLER, Norman, DJOJOSUBROTO, Meta, RUDOLPH, Karl Lenhard, MANNS, Michael, ZENDER, Lars, KUBICKA, Stefan
Format Journal Article
LanguageEnglish
Published Philadelphia, PA American Association for Cancer Research 2005
Subjects
Antineoplastic agents
Biological and medical sciences
Chemotherapy
Gastroenterology. Liver. Pancreas. Abdomen
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Medical sciences
Pharmacology. Drug treatments
Tumors
Antineoplastic agent
Protein MCL-1
Enzyme
Ligand
Cytokine
Elimination
Virotherapy
Hepatic disease
Hepatocellular carcinoma
Malignant tumor
Resistance
Chemotherapy
Treatment
Tumor necrosis factor
Cell death
Digestive diseases
Antiviral
TNF related apoptosis inducing ligand
Telomerase
Apoptosis
Online AccessGet full text

Cover

More Information
ISSN:0008-5472
1538-7445